| Mepha Pharma AG - Olmesartan-Mepha Teva 40 mg, Filmtabletten | | 68523 | | 03 | | Olmesartan-Mepha Teva 40 mg | | Filmtabletten | | C09CA08 | | Olmesartan medoxomil | | 08.06.2022 | | |
| | Composition | | olmesartanum medoxomilum 40.0 mg, lactosum monohydricum 302.12 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 2.77 mg, macrogolum 3350, triacetinum, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Olmesartanum Medoxomilum | 40 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Olmesartan Medoxomil | 40 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Cellulosum Microcristallinum | | | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 2.77 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Titanium Dioxide | | | | Triacetinum | | |
| |
| |
|
